Hologic INC Schedule 13G passive stakes

Filed when an investor crosses five percent without intending to seek control — the passive counterpart to a 13D.

Vanguard Capital Management has reported a beneficial ownership of 7.49% in Hologic Inc. common stock as of March 31, 2026.
The Vanguard Group has amended its Schedule 13G for Hologic Inc., reporting 0% beneficial ownership following an internal realignment that shifts reporting to its subsidiaries.
T. Rowe Price Investment Management, Inc. has disclosed an updated beneficial ownership of 9.7% in Hologic Inc., holding over 21.5 million common shares.
T. Rowe Price Investment Management, Inc. has disclosed a significant beneficial ownership stake of 10.8% in Hologic Inc., totaling over 24 million shares of common stock.
BlackRock, Inc. has filed an amended Schedule 13G, disclosing a passive beneficial ownership of 8.9% of Hologic Inc.'s common stock as of March 31, 2025.
T. Rowe Price Investment Management, Inc. has filed an updated Schedule 13G, revealing a 7.9% beneficial ownership stake in Hologic Inc.'s common stock as of December 31, 2024.